chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This pt's mother came to clinic for a scheduled medical appointment. At that time pts mother asked for a new covid vaccine card because she lost her previous card. When our clinic staff nurse looked up the mother's information in the state vaccine site she noticed that she had received her booster dose too early. That early dose was administered by a grocery store pharmacy, not our clinic. Mother then stated that her daughter (this pt) also received a covid shot at the grocery store pharmacy. When the administering nurse looked up that child (this pt) she identified that pharmacy administered this patient's second primary series dose too early. Again, as with her mother, this vaccine admin error was not done by our clinic. Pt had no adverse medical events.  Mother's vaers report confirmation: 864017 for reference. This writer submitted that report as well.
Approximately 1 hour after immunizations were administered, patient's mother called clinic stating patient had a red rash all over her body which was very itchy and patient was also complaining of feeling like there was a horse in her throat.  Parents were instructed to bring her back immediately.  They arrived within 10-15 minutes.  She was noted to have a highly erythematous rash from head to toe which was quite pruritic.  No angioedema or respiratory distress.  She was treated with an IM injection of Benadryl and a SQ injection of epinephrine.  Her symptoms resolved very quickly.
(+) small flesh colored papules on his abdomen and back noted 2.5 days after his 1 year old vaccines. At the clinic on 7/29/2021 325pm (+) small red papules on the chest, abdomen and thighs. No medications given. In other ways advised rashes will spontaneously.
PATIENT CALLED PHARMACY ON 4/21/21 EXPLAINING LOCAL INJECTION SITE REACTION.   PHARMACIST ADVISED ON SELF CARE MEASURES  AND RECOMMENDED IF NO IMPROVEMENT OR WORSENING SYMPTOMS 3 DAYS AFTER (4/22/21) TO FOLLOW UP WITH MEDICAL DOCTOR VIA VIDEO VISIT, URGENT CARE, OR PRIMARY CARE PHYSICIAN OFFICE.  PATIENT DID NOT ENDORSE SWELLING/PAIN AT INJECTION SITE BUT EXPLAINED A BULLSEYE RASH WITH SURROUNDING ERYTHEMA.  PATIENT SENT PICTURE TO TECHNICIAN CELL PHONE.  PATIENT PRESENTED TO PHARMACY ON 4/22/21 AND SPOKE WITH PHARMACIST.  PHARMACIST OBSERVED AN INJECTION SITE REACTION AT SITE OF INJECTION AND COUNSELED ON SELF CARE MEASURES AND RECOMMENDED TO FOLLOW UP WITH MEDICAL DOCTOR IF NO IMPROVEMENT AND/OR IF ANY SYMPTOMS WORSEN.  PHARMACIST DID NOT SUSPECT CELLULITIS BECAUSE PATIENT DENIED THAT SITE WAS PAINFUL TO TOUCH.
Rash and itching all over body. First was given Benadryl, Zyrtec and famotidine. Second trip to er was given hydroxyzine hcl
Apparent syncopal reaction.  2-3 minutes after receiving her dose, the patient was standing in the checkout line and began to lose her balance nearly striking her head on the checkout counter.  This progressed to a gradual collapse, eased to the ground by her father.  She was then carried to a nearby chair where she recovered over the next few minutes, first responding verbally and then opening her eyes.  She commented her vision started to go black and didn't really remember anything that followed, including fainting.  Patient was stable after about 5 minutes and back to baseline without further issues, able to ambulate steadily and independently.  No further issues noted.
Patient reported fatigue and progressive weakness since given vaccination.  Now admitted to ICU in hypercarbic and hypoxemic respiratory failure on invasive vent support.
Cough, SOB, wheezing, intermittent fever, body aches, diarrhea onset after Moderna vaccine August 2021.
Information has been received a nurse practitioner concerning an adult female who "several years ago" was vaccinated with a third dose of Recombivax HB (manufacturer unknown). Subsequently over a 48 hour period the patient developed a faint rash on her stomach and a low grade fever of 99 degrees F. The outcome was recovered. It was not know if medical attention was sought. There was no product quality complaint involved. Follow-up information indicated that additional details were not available.
CHEST PAIN; PRETTY BAD HEADACHE; FEVER AS HIGH AS 103 DEGREES; This spontaneous report received from a patient concerned a 25 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: alcoholic, and non smoker, and other pre-existing medical conditions included: The patient had no medical history. Patient had no known allergies and no known drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 213D21A, expiry: UNKNOWN) dose was not reported, administered on 14-NOV-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-NOV-2021, the patient experienced fever as high as 103 degrees. On 15-NOV-2021, the patient experienced pretty bad headache. Laboratory data included: Body temperature (NR: not provided) 103 degrees. On 17-NOV-2021, the patient experienced chest pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever as high as 103 degrees, and pretty bad headache on NOV-2021, and had not recovered from chest pain. This report was non-serious.
Patient claims that every since receiving the Fluvirin Vaccine he is allergic to Sea Food, and he was never allergic to sea food previously.
Pt awoke feeling disoriented and sweating profusely. Pt checked blood glucose levels which were within normal limits. Pt states feeling "in a fog" throughout the day. Pt states all symptoms were gone the next day.
4-10-13 - Fever 104.6, 9x7 cm diameter erythema and induration on (R) deltoid. Rx'd Clindamycin 300mg cap, 2 cap TID x 10 days. Painful area. 4-11-13 - Fever 99.2, area 10.5 cm erythema and induration, itchy. BENADRYL added.
patient got sick; passed the 42 days window; This spontaneous case was reported by a physician and describes the occurrence of ILLNESS (patient got sick) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (passed the 42 days window) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (passed the 42 days window). On an unknown date, the patient experienced ILLNESS (patient got sick). At the time of the report, ILLNESS (patient got sick) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (passed the 42 days window) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD21-081725 (E2B Linked Report).; Sender's Comments:  MOD21-081725:
My daughter had a seizure it lasted around 5 minutes. Her body became stiff and her hands were curled and her hands were shaking. After a few minutes, she opened her eyes but was unresponsive. She kept sleeping and around 2 am she yelled in her sleep and started to shake briefly again. She fell back asleep and I scheduled an appointment with her provider.
Developed polyarticular arthritis approx 9 days after vaccination with new +antiDS DNA testing concerned for lupus like drug reaction
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Medium, Additional Details: Patient did not have complaints during her 15 minute waiting period each time technician checked in on her. When the techinician told her her 15 minutes have elapsed, she complained of dizziness and fainted soon after.  She regained consciousness after a few seconds and then complained of nausea. Paramedics were immediately called when she fainted. They arrived in about 5 minutes and transported her to ER.
April 13, 2021  Moderna Vaccine   NDC#80777-273-99   Lot # 020B21A   Left Deltoid  Hx:  Allergic reaction (rash) to Vancomycin   9:17 ? Received Vaccine Pt instructed to wait 30 minutes due to history 9:40   presented with red rash and itching EMS notified Benadryl 50 mg IM given to R deltoid 9: 41 Epi 0.3ml IM given R deltoid VS   B/P   160/100   HR   95   O2 sat 99%   R 22 9:45   EMS arrived   Pt evaluated and transported to Hospital   VAERS and ARIA filed   5:00 p.m.   Follow up phone call to patient Pt states she received steroid injection and oxygen Prescriptions for Steroid treatment and Benadryl given  She still complains of rash, itching and a scratchy throat. Instructed patient if symptoms become worse to seek medical attention.
Pink oval shaped knot on the site of the injection arm; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events pink oval shaped knot on the site of the injection arm..  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 5 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 5 Feb 2021, the patient experienced the event(s) pink oval shaped knot on the site of the injection arm..  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), pink oval shaped knot on the site of the injection arm. was unknown..
This spontaneous report was received from a nurse and refers to a 5 year old patient of unknown age. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 22-AUG-2017, the patient was vaccinated with the first dose of PROQUAD (dose, route of administration, lot # and expiry date were not provided) reconstituted with sterile diluent (STERILE DILUENT). On 27-SEP-2017, the patient was vaccinated with the second dose of PROQUAD (dose, route of administration were not provided, lot # reported as N019251, expiry date 20-DEC-2018) reconstituted with sterile diluent (STERILE DILUENT). No adverse effects were reported.
My 11 year old daughter got her period for the 1st time the same day as her 1st injection for Covid-19.
headache; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 13Jan2021 at single dose for covid-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient received her first dose this afternoon on 13Jan2021, but has developed a headache, the patient wanted to know if she can take some ibuprofen. The outcome of the event was unknown.  No follow up attempts are possible; information about lot/batch number cannot be obtained.
Diarrhea; Headache; Lightheadedness; Sluggish feeling; In general he feels off; Chest pain; Little bit of nausea; Tired; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from medical information team, Program ID: (159558). The reporter is the patient.  A 69-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 25Sep2023 as dose 7 (booster), single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, single; lot number: unknown), for COVID-19 immunization; Bnt162b2 (dose 2, single; lot number: unknown), for COVID-19 immunization; Bnt162b2 (dose 3 (booster), single; lot number: unknown), for COVID-19 immunization; Bnt162b2 (dose 4 (booster), single; lot number: unknown), for COVID-19 immunization; Bnt162b2 (dose 5 (booster), single; lot number: unknown), for COVID-19 immunization; Bnt162b2 (dose 6 (booster), single; lot number: unknown), for COVID-19 immunization. The following information was reported: CHEST PAIN (non-serious) with onset Sep2023, outcome "unknown"; DIARRHOEA (non-serious) with onset Sep2023, outcome "unknown", described as "Diarrhea"; HEADACHE (non-serious) with onset Sep2023, outcome "unknown"; MALAISE (non-serious) with onset Sep2023, outcome "unknown", described as "In general he feels off"; DIZZINESS (non-serious) with onset Sep2023, outcome "unknown", described as "Lightheadedness"; NAUSEA (non-serious) with onset Sep2023, outcome "unknown", described as "Little bit of nausea"; SLUGGISHNESS (non-serious) with onset Sep2023, outcome "unknown", described as "Sluggish feeling"; FATIGUE (non-serious) with onset Sep2023, outcome "unknown", described as "Tired". The event "chest pain" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The patient received the new Pfizer COVID-19 vaccine on 25Sep2023. He experienced a series of symptoms; mentioned diarrhea most of the week, headache, a little bit of nausea, lightheadedness, sluggish feeling, tired, and feels off. The patient was asking if these were expected with the vaccine. This was his 7th vaccine, he also had Pfizer for the previous 6 vaccines. The patient mentioned that the whole week he was totally off and thrown for a loop since he came back from vacation. He went to the gym as he does every morning and towards the end of a spinning class which gets the heart pumping, he experienced chest pain and went to the hospital. He does not know if it was tied to the vaccine. The doctors did not state that it was the cause, but it was weird and made it seemed like it was. He had an EKG and blood work and they were negative. He also had to do stress test. The patient stated that he was not going to complain but just wanted to verify why he's feeling these.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm is very sore), HEADACHE (Headache is bad and MYALGIA (achy all over/achy and sore today) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, the patient experienced PAIN IN EXTREMITY (arm is very sore), HEADACHE (Headache is bad) and MYALGIA (achy all over/achy and sore today). At the time of the report, PAIN IN EXTREMITY (arm is very sore), HEADACHE (Headache is bad) and MYALGIA (achy all over/achy and sore today) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment medications were reported.
herpes zoster, postherpetic neuralgia, and vision problems.; herpes zoster, postherpetic neuralgia, and vision problems.; herpes zoster, postherpetic neuralgia, and vision problems.; This initial spontaneous report was received from a lawyer on 11-JAN-2021, regarding a case in litigation and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On 17-DEC-2013, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for its intended purpose: the prevention of shingles (herpes zoster) (no additional dosage regimen information was provided). After receiving the vaccine, on an unknown date, the patient experienced herpes zoster, postherpetic neuralgia and vision problems. As a result of these symptoms, the patient was treated by medical providers and at the time of the report was still under their care. As a direct and proximate result of vaccination, the patient's symptoms have resulted in physical limitations not present prior to using the product. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of their condition. The patient sustained severe and permanent personal injuries. Further as a tragic consequence of vaccination, the patient suffered serious, progressive, permanent and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life and physical impairment and injury.  The reporter considered that herpes zoster, postherpetic neuralgia and vision problems were related to zoster vaccine live (ZOSTAVAX). The reporter considered this case as serious due to patient's disabling conditions.
This case was reported by a pharmacist via call center representative and described the occurrence of headache in a 62-year-old female patient who received SHINGRIX (batch number EK279, expiry date 31st March 2020) and (batch number X3M27, expiry date 20th August 2020) for prophylaxis. On 16th April 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On an unknown date, the dose was an unknown dose. On 16th April 2018, less than a day after receiving SHINGRIX, the patient experienced headache, shivering, generalized erythema and fever. On 17th April 2018, the outcome of the headache, shivering, generalized erythema and fever were recovered/resolved. The reporter considered the headache, shivering and fever to be probably related to SHINGRIX. The reporter considered the generalized erythema to be possibly related to SHINGRIX. Additional details were provided as follows: The patient received the SHINGRIX vaccine in left deltoid. The patient's whole body turned red.
I had no effect until  after i went to sleep.. After midnight i awoke to itching all over. By morning my eyes were closed to slits and beneath my eyes were  bags as large as teabags, i also had a low grade fever, aches and pains and extreme fatigue. This lasted for a while so ,on Feb 2.. I went to the doctor who gave me a steroid shot. On the 4th  i was not as  achy though still tired and the bags under my eyes persisted ...My eyes were  still itchy and almost closed... She gave me another steroid shot.. i was also advised not to get second steroid shot by several doctors, a doctor and a Immunologist.. also advised against getting second dose. The fatigue remains and the swelling under eyes remains though not as pronounced as it was at first. I would like to be safe. Is the johnson and johnson an option for me? I would not like after effects Please get back to me with some suggestions and advice as to my being fully safe. thank you.
TREMORS; 8 WEEKS OF UPSET STOMACH; SORE ARM; MUSCLE WEAKNESS; FATIGUE; 8 WEEKS OF DIARRHEA; FEVER; This spontaneous report received from a patient via a company representative concerned an 8 decade old of unspecified sex. The patient's height, and weight were not reported. The patient's concurrent conditions included: pennicillium allergy, and sulfa allergy, and other pre-existing medical conditions included: The patient was in relatively good health and do not take medication for any long term or chronic conditions. The patient has a natural redhead and had a fair skin and has reaction to anesthesia. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 04-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced tremors, 8 weeks of upset stomach, sore arm, muscle weakness, fatigue, 8 weeks of diarrhea, and fever. Laboratory data (dates unspecified) included: Blood test (NR: not provided) nothing was wrong, Sigmoidoscopy (NR: not provided) nothing was wrong, and Stool analysis (NR: not provided) nothing was wrong. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from 8 weeks of diarrhea, and the outcome of sore arm, fatigue, muscle weakness, tremors, fever and 8 weeks of upset stomach was not reported. This report was non-serious.
Left Tricep with localized area of 4X4Cm of redness and mild swelling. No pain some itching per patient.
Severe joint pain-elbows, shoulders, knees, hips, and wrist.  24 hours  Swollen lymph nodes in neck and left armpit-over 48 hours--still persisting 2 days later
pt exp chills, t102, body aches, h/a, gen malaise 24hr post vax;
The patient reported that she had problems using her left arm. then she came back after about a month and indicated that her arm was paralyzed  and she is still having problems with her left arm up till now
Started with a very bad headache, then pain in the left arm, then the left arm I could not lift it above my head, then my legs started hurting, I had a lot of pain in my legs, and I could not sleep that night due to the pain. I took two Tylenol every 4 hours starting at 8:00am the next morning, and I had a fever, this is why I started taking the Tylenol I had a fever of about 101. At 8:00 am. The Tylenol treatment lowered the fever and it took away the headaches, and then I could not eat very well, I could only eat soup all day, it was very painful to sit up so I lay in bed all day. My fingertips were all freezing cold, on both hands I had to wear gloves to warm them up. I did not called my medical Dr. I called my sister who is also a medical Dr. and asked her were these symptoms normal and she stated yes except for the cold hands and she just suggested that I just rest and it would go away in 24hrs, and she was correct it did. Just after 24 hours all of the symptoms went away, my arm was still a bit sore but it has all went away now.
On 2/14 the patient describes the typical symptoms of a sore arm at the injection site. The patient reports an expected decrease in symptoms until 2/22/21, when the injection site became itchy and swollen, and developed a slight rash. I advised the patient to take Tylenol for pain/fever (especially for her second dose on 2/24/21), to take Benadryl at nighttime for the rash, and to use some OTC topical lidocaine for the itching/discomfort as needed.
RASH DEVELOPED ABOUT 2 DAYS AFTER INJECTION, AND STARTED GROWING IN SIZE.  THERE WAS NO PAIN OR ITCH, BUT SKIN WAS WARM TO THE TOUCH.  WENT TO HOSPITAL AND WAS GIVEN CEPHALEXIN.  AFTER 2 DOSES IT SEEMS THE RASH IS LESSENING AND FADING IN COLOR.